Technology

Chimerix

$8.51
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.43 (-4.64%) Today
-$0.21 (-2.46%) As of 12:41 PM UTC after-hours

Why Robinhood?

You can buy or sell Chimerix and other stocks, options, and ETFs commission-free!

About CMRX

Chimerix, Inc. Common Stock, also called Chimerix, is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded by George R. Painter, III and Timothy Wollaeger in April 2000 and is headquartered in Durham, NC. The listed name for CMRX is Chimerix, Inc. Common Stock.

CEO
Michael A. Sherman
Employees
43
Headquarters
Durham, North Carolina
Founded
2000
Market Cap
713.36M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.65M
High Today
$9.23
Low Today
$8.52
Open Price
$8.83
Volume
1.22M
52 Week High
$10.72
52 Week Low
$1.19

Collections

CMRX Earnings

-$0.37
-$0.25
-$0.12
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 23, Pre-Market

You May Also Like

PNM
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure